Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
AI maakt onderscheid tussen Parkinson, MSA en PSP
jul 2025 | Bewegingsstoornissen